Nathan Bahary

4PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 01, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.

Philip A Philip, Vaibhav Sahai, Nathan Bahary

|May 16, 2023
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Talal El Zarif, Amin H Nassar, Elio Adib

|Jul 11, 2018
Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer.

Prakash C Thakur, Jennifer L Miller-Ocuin, Khanh Nguyen

|Jan 06, 2018
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences.

Diwakar Davar, Nathan Bahary

Pageof 1

Frequent Collaborators

1 joint publications

Talal El Zarif

1 joint publications

Amin H Nassar

1 joint publications

Bailey G Fitzgerald

1 joint publications

Jiaming Huang